Clinical Trials Sponsored by Saie Beauty

Total 251 results

Saie Beauty

Completed

Study to Identify if Saie Beauty's Under Eye Concealer Works to Improve Under-Eye Skin Appearance and Reduce Imperfections

Wrinkle

United States
Beauty Health

Active, not recruiting

Evaluation of Efficacy and Safety of the Skinstylus Sterilock Microneedling System for the Treatment of Facial Wrinkles

Subjects Displaying Facial Ageing

United States
Safe Save Medical Cell Sciences & Technology Co...

Unknown

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme

Taiwan
Bend Beauty Inc.

Withdrawn

Effects of Bend Beauty's Anti-Aging Formula on Inflammatory Markers (BENCHMARK)

Inflammation | Inflammatory Response | Skin Abnormalities | Skin Pigment | Skin Inflammation

Canada
Procter & Gamble Beauty

Completed

Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States
Dime Beauty Co.
Citruslabs

Completed

A Comparative Split-Face Study of the Effects of a Retinol Alternative Cream on Improving Facial Skin Aging

Skin Aging

United States
Embody Beauty, Inc.
Citruslabs

Completed

Study To Investigate If Embody's Retinol Gummies Improve The Early Signs Of Skin Aging And Overall Skin Health

Acne, Adult

United States
Dime Beauty Co.
Citruslabs

Completed

A Single-Group Study to Evaluate the Effects of an Eyelash Serum on Improving Eyelash Growth

Eyelash Growth

United States
Dime Beauty Co.
Citruslabs

Completed

A Clinical Trial to Evaluate the Effects of an Eye Serum on Improving the Appearance of the Periorbital Area

Periorbital Area

United States
Universal Skincare Institute
Lavish Beauty

Completed

Straberi Microneedling For Atrophic Acne (SAA)

Atrophic Acne Scar

United States
Universal Skincare Institute
Lavish Beauty

Completed

Straberi Epistamp Device for Postinflammatory Hyperpigmentation (EPH)

Postinflammatory Hyperpigmentation

United States
Universal Skincare Institute
Lavish Beauty

Completed

Straberi Epistamp Needling Treatment For Skin Rejuvenation (ESAA)

Wrinkle | Collagen Degeneration | Elastic Skin

United States
Brock Beauty Inc.
KGK Science Inc.

Completed

A Clinical Trial to Evaluate the Effectiveness of Hairfinity on Improving Hair Health and Rate of Growth

Healthy Participants

Canada
Sage Therapeutics

Completed

An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus

Tinnitus

United States
Sage Therapeutics

Completed

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

Parkinson Disease | Cognitive Dysfunction

United States
Sage Therapeutics

Completed

Evaluate SAGE-547 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Completed

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus (SRSE)

Super-refractory Status Epilepticus

United States
Sage Therapeutics

Completed

A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B

Huntington Disease

United States
Sage Therapeutics

Completed

A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)

Postpartum Depression

United States
Sage Therapeutics

Completed

A Study With SAGE-547 for Super-Refractory Status Epilepticus

Super-Refractory Status Epilepticus

United States, Austria, Canada, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Serbia, Spain, Sweden, United Kingdom
Sage Therapeutics

Completed

Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression

Postpartum Depression

United States
Sage Therapeutics

Completed

Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants

Healthy Volunteer

United States
Sage Therapeutics

Withdrawn

A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)

Postpartum Depression
Sage Therapeutics

Recruiting

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease

Huntington Disease

United States, Canada
Sage Therapeutics

Recruiting

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

Huntington's Disease

United States, Australia, Canada, United Kingdom
Sage Therapeutics

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Active, not recruiting

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Huntington Disease

United States
Sage Therapeutics

Completed

A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting

Postpartum Depression

United States
Sage Therapeutics

Terminated

A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)

COVID-19 | Acute Respiratory Distress Syndrome

United States
Sage Therapeutics

Completed

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

Severe Postpartum Depression

United States
Sage Therapeutics

Recruiting

A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Sage Therapeutics

Active, not recruiting

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease | Mild Dementia

United States, Puerto Rico
Sage Therapeutics

Completed

A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment

Parkinson Disease | Cognitive Dysfunction

United States
Sage Therapeutics

Completed

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Cognitive Dysfunction | Alzheimer Disease | Mild Dementia

United States
Sage Therapeutics

Completed

A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)

Post Partum Depression

United States
Sage Therapeutics

Completed

A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Healthy Volunteer

United States
Sage Therapeutics

Completed

A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)

Postpartum Depression

United States
Sage Therapeutics

Approved for marketing

Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression

Postpartum Depression
Sage Therapeutics

No longer available

An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus

Super-Refractory Status Epilepticus
Instituto de Investigación Sanitaria Aragón
BIT BEAUTY SL.

Completed

Beauty as a State of Wellness Beauty as a State of Wellbeing in Women 40 to 64 Years of Age

Stress, Physiological | Mood | Self Esteem | Psychological Well-being

Spain
Integrative Skin Science and Research
Codex Beauty Corporation

Not yet recruiting

A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome

Acne Vulgaris

United States
Port Said University

Not yet recruiting

Promoting Whistleblowing Among Nurses: A Randomized Controlled Trail

Nurse's Role
Sage Therapeutics
Biogen

Recruiting

Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Port Said University

Not yet recruiting

Effect of Inter-professional Collaboration Training Program on Nurses' Collegial Solidarity and Knowledge Sharing

Nurses Behaviors
Russell Sage College

Completed

Effectiveness of Music Practical Examinations

Stress | Test Anxiety

United States
GlaxoSmithKline
Sage Analytica

Completed

Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009

Respiratory Syncyctial Virus Vaccines
GlaxoSmithKline
Sage Analytica

Completed

Influenza Burden Assessment in the United Kingdom, 1996-2008

Influenza
Sage Therapeutics
Biogen

Active, not recruiting

Study to Evaluate SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States

3

Subscribe